GSK3B and Alzheimer disease: The ventral mossy cell‐specific overexpressing hTau disrupted multiple AD‐associated signaling pathways, including reduction of synapse‐associated protein, inhibition of AKT and activation of glycogen synthase kinase (GSK‐3β).